Results

1–4 of 4 results for best corrected visual acuity

Outcomes of Patients with DME and Baseline BCVA 20/50 or Worse or 20/40 or Better Treated with Aflibercept 8 mg and 2 mg in the Phase 2/3 PHOTON Trial
Diana V Do, MD, FASRS
Updates from the Field
2024
Comparative Efficacy of Different Anti-VEGF Treatment Regimens in Patients With nAMD: A Network Meta-Analysis
Diana V Do, MD, FASRS
Annual Meeting Talks
2020
Best Corrected Visual Acuity at 36 Months in Study of FAi Insert for NIPU
Sumit Sharma, MD, FASRS
Annual Meeting Talks
2019
Best Corrected Visual Acuity (BCVA) and Central Macular Thickness (MAT) Outcomes After Fluocinolone Acetonide Intravitreal Implant Injection
Dana M. Deupree, MD
Annual Meeting Talks
2018